AlphAIalphai — Financial news for AI agents
SEC EDGARJUN 32 min read$ENVA

GOODYEAR WILLIAM M sold $976K of ENVA

GOODYEAR WILLIAM M sold 5,983 shares of Enova International, Inc. (ENVA) at $163.13 ($0.98M total) on 2026-06-01.

Original reporting
SEC EDGAR · GOODYEAR WILLIAM M
Published Jun 3, 2026, 8:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 3, 2026, 8:41 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$ENVA
Neutral
medium confidence
Mentioned
$ENVA
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ENVANeutralLow
01

Why it matters

This provides incremental sentiment information (insider reducing exposure), but it does not change ENVA’s fundamentals based on the article alone.

02

Market read

Traders may monitor for additional insider activity or confirm whether the sale is part of a broader pattern, but there is no direct fundamental catalyst here.

03

What to watch

The article doesn’t specify whether the director’s broader selling program exists beyond this transaction; also, insider sales often have limited predictive power without clustering or follow-on disclosures.

Relevance 6/10Novelty 6/10Timing: SEC Form 4 filed June 3 for a June 1 sale

Background

The filing is an SEC Form 4 insider transaction: director GOODYEAR WILLIAM M sold ENVA shares on June 1; the filing was made June 3.

Company-level read

Ticker impact

$ENVANeutralMedium confidence
Context

Enova director GOODYEAR WILLIAM M sold 5,983 shares in an open-market transaction worth about $976K, disclosed via SEC Form 4.

Expected impact

Low near-term impact; any reaction is likely limited unless follow-on selling or new fundamentals emerge.

Evidence & confidence

This is an ownership-change disclosure (Form 4) with modest dollar value relative to typical market caps; no new company-specific operational or financial information is provided.

Market effects

Sector

Minimal—this is company-specific insider activity with no stated sector/regulatory trigger.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

The sale may be routine liquidity management rather than a negative view, especially with no accompanying negative news in the filing.

Key entities

  • issuer
    Enova International, Inc.

    Subject of the insider transaction disclosure; director sold shares open-market.

  • insider
    GOODYEAR WILLIAM M

    Director who executed the reported sale of ENVA shares.

Read at source← All news

Related articles

JUL 29
$OPFIMed

OppFi and Enova Bank Deals Put Lending Under Scrutiny

Attorneys general asked the Federal Reserve, OCC and FDIC to deny banking privileges tied to OppFi’s $130M acquisition of BNCCORP and BNC National Bank and Enova’s proposed acquisition of Grasshopper Bancorp and Grasshopper Bank. AGs allege bank partnerships bypass state loan-rate caps and cite high rates and charge-offs. OppFi and Enova project deposit and revenue synergies and EPS accretion.

pymnts.com5 min
JUL 26
$ENVAMed

ENVA Rallies As Enova Tops Q2 And Targets Grasshopper Bank Synergies

Enova International Inc. (NYSE: ENVA) shares rose about 9% after Q2 results and guidance-related optimism. The company reported adjusted EPS of $4.31 vs $3.96 consensus and revenue of $928.9M vs $764M prior year, with operating cash flow of $544M and $531.4M free cash flow. Analysts reportedly raised price targets to $257-$280, citing the Grasshopper Bank acquisition and improving credit metrics.

stockstotrade.com4 min
JUL 26
$ENVAMedAI 8/10

Enova International Stock Jumps After Powerful Q2 Beat

Enova International Inc. (NYSE: ENVA) shares rose about 9% during the week after the company reported Q2 2026 results and raised guidance. Adjusted EPS was $4.31 versus $3.96 expected, with revenue up to $928.9M from $764M. Management cited record $5.5B loans, improving margins, and ongoing share repurchases.

timothysykes.com6 min
JUL 26
$ENVAMed

ENVA Jumps As Enova Earnings Beat Fuels Bullish Targets

Enova International Inc. (NYSE: ENVA) shares rose about 9% after its Q2 2026 results. The company reported adjusted EPS of $4.31 versus $3.23 a year earlier and revenue of $928.9M versus $764M, alongside a consumer credit outlook. Analysts cited bullish targets of $257 to $280 and support near $230.

stockstotrade.com6 min
JUL 26
$ENVAMedAI 8/10

Enova International Signals Strong Growth and Rising EPS

Enova International (ENVA) reported Q2 results and said consolidated originations rose 27% YoY to nearly $2.3B and total revenue rose 22% to $929M. Adjusted EPS increased 33% YoY to $4.31. Credit metrics improved, with net charge-offs at 7.3%. Management raised Q3 and 2026 guidance and noted the pending Grasshopper Bank deal awaits regulatory approval.

theglobeandmail.com6 min
JUL 25
$ENVAMedAI 8/10

Enova Reports Second Quarter 2026 Results

Enova International (NYSE: ENVA) reported Q2 2026 results. Total revenue rose 22% to $929 million. Diluted EPS was $4.00, up 40%, and adjusted EPS was $4.31, up 33%. Credit metrics stayed strong, with net charge-offs at a 7.3% ratio and net revenue margin at 61%. Enova also repurchased $19 million of stock and reported $929 million liquidity at June 30.

aol.ca6 min